A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive–compulsive disorder

Authors

Institutions

Publication Details

Journal
Journal of Psychopharmacology
Published
2026-03-13
DOI
https://doi.org/10.1177/02698811261424214
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive–compulsive disorder

Francisco Moreno, Christopher B. Wiegand, James I. Prickett, J.D. Allen et al.
Journal of Psychopharmacology
Psychedelics and Drug Studies
article

A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive–compulsive disorder

Francisco Moreno, Christopher B. Wiegand, James I. Prickett, J.D. Allen, Katja Ehrmann Allen, Rajan Dunne, Brian Bayze
article en

Abstract

No abstract available for this paper.
Journal of Psychopharmacology
University of Arizona (US)
Good health and well-being
Openalex Percentile: Top 27%
Psychedelics and Drug Studies
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive–compulsive disorder — Francisco Moreno, Christopher B. Wiegand, et al. · Journal of Psychopharmacology (2026) | TGRS Research Map | TGRS